GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Example 130 [US20140194408] | GDC-0853 | GDC0853 | RG-7845 | RG7845
Compound class:
Synthetic organic
Comment: Fenebrutinib (RG7845, GDC-0853) is a reversible noncovalent Bruton's tyrosine kinase (BTK) inhibitor, that was proposed for therapeutic potential in difficult-to-treat autoimmune diseases, including multiple sclerosis [9]. The compound is claimed in patent WO2013067274 [3]. It interacts with BTK in its inactive confirmation.
|
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||